Solid Rock Principled Capital

We Are A Private Equity Firm With Biomedical Expertise

Key Stakeholders

Investors

earn potential attractive returns in biomedical companies

Advisors

chosen for world class expertise and connection in target investment areas

Managers

bring significant biomedical, entrepreneurial and M&A experience

Investments

are identified and vetted through experience and time tested investment screens

>The benefits of our approach include<

Potential attractive return on investment through a portfolio of companies

Roll-up strategy mitigates financial risk

Hands-on insight and involvement from fund manager with industry experience

Growing health care industry facilitates opportunities

Meet us @ the JP Morgan Healthcare Conference Jan. 7-10,

... or ...

Come to our presentation Jan. 31, 2019 @ the
Health INNOVATIONS Summit

Media Coverage of Summit